JANICE TRINH: Open Payments
NPI 1760261507 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,031 in 44 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $481 · 2025 $1,031
Food & beverage: $1,031
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $235 |
| Lilly USA, LLC | 9 | $159 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| Seqirus USA Inc | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $51 |
| Amgen Inc. | 2 | $48 |
| Medtronic, Inc. | 1 | $44 |
| PFIZER INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
Products named: MOUNJARO, Wegovy, Ozempic, Rybelsus, REXULTI, SYMPLICITY G3, PREVNAR 20, Flucelvax.
Industry payments across CO — which companies pay providers there.
